Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T02:20:08.718Z Has data issue: false hasContentIssue false

S48.02 - Effect of Serotonin-1A receptor on behavioral changes in animal model of schizophrenia-like behavior

Published online by Cambridge University Press:  16 April 2020

V. Bubenikova-Valesova
Affiliation:
Prague Psychiatric Center, Prague, Czech Republic
M. Votava
Affiliation:
3rd Faculty of Medicine Charles University, Prague, Czech Republic
T. Palenicek
Affiliation:
Prague Psychiatric Center, Prague, Czech Republic
J. Horacek
Affiliation:
Prague Psychiatric Center, Prague, Czech Republic 3rd Faculty of Medicine Charles University, Prague, Czech Republic
C. Hoschl
Affiliation:
Prague Psychiatric Center, Prague, Czech Republic 3rd Faculty of Medicine Charles University, Prague, Czech Republic

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Some antipsychotics act as partial agonists on serotonin-1A receptors (5-HT1AR) localized postsynaptically in cortex and hippocampus and presynaptically on the serotonergic cell bodies and dendrites in raphe nuclei.

Our study's aim was to investigate the effect of pre- and postsynaptic 5-HT1AR activation on MK-801 (0.1, 0.3 mg/kg)-induced sensorimotor gating deficits and hyperlocomotion in a rat model of schizophrenia-like behavior. To investigate the effect of presynaptic receptor activation we used a partial agonist (buspirone; 1,10 mg/kg) and a low dose of full agonist (8-OH-DPAT; 0.025 mg/kg). The effect on both pre- and postsynaptic receptors was investigated by a high dose of full agonist (8-OH-DPAT; 1 mg/kg).

We found that buspirone in both doses had no effect on MK-801-induced deficit in senzorimotor gating. Contrarily, the low dose of 8-OH-DPAT ameliorated the deficit. The MK-801-induced hyperlocomotion was decreased by buspirone as well as by the low dose of 8-OH-DPAT. Activation of both pre- and postsynaptic 5-HT1AR had an opposite effect on MK-801-induced behavior.

Our findings accord with the published results that partial 5-HT1AR agonists could be effective in schizophrenia treatment, but full potent agonists could exacerbate psychotic symptoms. Observed differences between buspirone and the low dose of 8-OH-DPAT could be due to inhibition of D2 receptor.

This research was supported by grant MZ0PCP2005 from the MZCR and by the projects 1M0517 from the MSMT

Type
Symposium: The role of 5-HT1AR in pathophysiology and treatment of schizophrenia
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.